Cargando…
The prognostic value and immune correlation of IL18 expression and promoter methylation in renal cell carcinoma
BACKGROUND: Renal cell carcinoma (RCC) is not sensitive to immunotherapy and has poor prognosis. DNA methylation regulates gene expression, and its abnormal changes are related to many human diseases. Recently, DNA methylation has been found to participate in immune infiltration in various cancers....
Autores principales: | Wang, Xiaonan, Zhu, Wancui, Long, Qian, Chen, Enni, Sun, Haohui, Li, Xiaodi, Xu, Hailin, Li, Weizhao, Dong, Pei, He, Liru, Chen, Miao, Deng, Wuguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883904/ https://www.ncbi.nlm.nih.gov/pubmed/36707882 http://dx.doi.org/10.1186/s13148-023-01426-8 |
Ejemplares similares
-
Prognostic, clinicopathological, and immune correlation of NLRP3 promoter methylation in kidney renal clear cell carcinoma
por: Long, Qian, et al.
Publicado: (2021) -
Prognostic value of JAK3 promoter methylation and mRNA expression in clear cell renal cell carcinoma
por: Long, Qian, et al.
Publicado: (2021) -
Prognostic value and immune landscapes of TERT promoter methylation in triple negative breast cancer
por: Lin, Fei, et al.
Publicado: (2023) -
FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma through TIE1-mediated PI3K/AKT signaling pathway
por: Chen, Enni, et al.
Publicado: (2023) -
CPT1A promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis
por: Tian, Tian, et al.
Publicado: (2022)